New retrospective outcomes data from Behavioral Innovations tracks measurable gains in communication, social and daily-living skills among children with autism, giving families fresh data when comparing Applied Behavior Analysis (ABA) therapy providers in Fort Worth, Texas. The findings...
As late-summer storms bring outages and unpredictable conditions to Minneapolis, emergency garage door service and backup access planning can help residential and commercial property owners reduce safety risks and costly downtime. MINNEAPOLIS, Aug. 28, 2026 /PRNewswire-PRWeb/ --...
MEXICO CITY, August 28, 2026--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of "a-" (Excellent) of Eureka-Re SCC (Eureka) (Barbados). The outlook of these Credit Ratings (ratings) is stable.
NEW YORK, Aug. 28, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Hyliion Holdings Corp. (NYSE American: HYLN) between May 12, 2026 and June 23, 2026, both dates inclusive...
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Bloom Energy Corporation ("Bloom Energy" or the "Company") (NYSE: BE) on behalf of investors that purchased or otherwise acquired Bloom Energy securities between February 27, 2025 and July 8, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Bloom Energy and have suffered losses, you may CLICK HERE to contact us. You may...
LOS ANGELES, Aug. 28, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to PROCEPT BioRobotics Corporation (PRCT) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PROCEPT...
HOUSTON, August 28, 2026--Lawdragon is celebrating the specialized yet versatile skills of three Hicks Thomas attorneys by selecting them for its inaugural 500 Special Situations Lawyers legal guide.
FDA determines JUUL2 System meets statutory standard of being "appropriate for the protection of public health" JUUL2 System incorporates a suite of innovative technology to better serve adults who smoke WASHINGTON, Aug. 28, 2026 /PRNewswire/ -- Yesterday, the U.S. Food and Drug...
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Rackspace Technology, Inc. ("Rackspace" or the "Company") (NASDAQ: RXT) on behalf of investors that purchased or otherwise acquired Rackspace securities between May 7, 2026 and July 8, 2026 (the "Class Period").CLICK HERE TO JOIN THE CASEIf you are an investor in Rackspace and have suffered losses, you may CLICK HERE to contact us. You may also contact...
San Antonio, TX, Aug. 28, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. ( NASDAQ: GROW ) will host a webcast on Friday, September 4, at 7:30 a.m. Central time to discuss the company’s results for fiscal year 2026.
PDA announced today that senior leaders from the FDA's centers for drugs, biologics and veterinary medicine as well as the Office of Inspections and Investigations will participate in the plenary on Monday, Sept. 14, as part of the 2026 PDA/FDA Joint Regulatory Conference in Washington, D....
VERAXA Biotech and Secarna Pharmaceuticals have reported an initial in vitro proof of concept for an antibody oligonucleotide conjugate (“AOC”) developed through their research alliance. The AOC candidate demonstrated greater potency than the equivalent unconjugated oligonucleotide in early testing, providing a first experimental validation of the collaboration. AOCs are an emerging class of antibody-guided therapies designed to use an antibody to deliver therapeutic oligonucleotides selectively to disease-relevant cells. VERAXA contributes antibody conjugation expertise and proprietary click chemistry, allowing it to participate in AOCs without shifting its core oncology strategy. The collaboration adds to VERAXA’s growing partnering track record, which also includes its bispecific ADC di